{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T11:11:05Z","timestamp":1783336265501,"version":"3.54.6"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T00:00:00Z","timestamp":1642550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T00:00:00Z","timestamp":1642550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>In Japan, there has been no investigation of regional differences in the number or amount of prescriptions of anxiolytics or hypnotics. Attributes related to the high amount of prescriptions for these drugs are unknown. We investigated recent trends and regional differences in the amount of prescriptions of hypnotics and anxiolytics in Japan and identified factors associated with these regional differences.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB) Open data from 2015 to 2018 were used. We calculated diazepam-equivalent doses (mg) for each drug and the total amount of prescriptions per capita for hypnotics and anxiolytics by sex and age. In addition, we calculated the standardized claim ratio (SCR) of the amount of prescriptions by prefecture. We investigated factors associated with regional differences in the SCRs of hypnotics and anxiolytics using the prefectures\u2019 medical, socioeconomic, and physical characteristics by an ecological study using a linear mixed-effects model.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The amount of prescriptions of hypnotics and anxiolytics, specifically, the amount of prescriptions of benzodiazepine receptor agonists (BZRAs), decreased in many of the adult age groups from 2015 to 2018. The regression analysis revealed that the number of medical clinics per capita, the number of public assistance recipients per capita, the proportion of persons whose HbA1c\u2009\u2265\u20096.5%, and the proportion of persons whose BMI \u226525\u2009kg\/m<jats:sup>2<\/jats:sup>were positively and significantly associated with the SCR of hypnosis. In contrast, the number of public assistance recipients per capita and the proportion of persons whose BMI \u226525\u2009kg\/m<jats:sup>2<\/jats:sup>were positively and significantly associated with the SCR of anxiolytics.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Factors associated with prescription amount of hypnotics and anxiolytics were revealed in this study, and a further study is needed for investigating causal relationships between the prescriptions amount and the associated factors using individual data.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12888-021-03657-6","type":"journal-article","created":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T14:04:52Z","timestamp":1642601092000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Analysis of regional differences in the amount of hypnotic and anxiolytic prescriptions in Japan using nationwide claims data"],"prefix":"10.1186","volume":"22","author":[{"given":"Tasuku","family":"Okui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsang","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,19]]},"reference":[{"key":"3657_CR1","unstructured":"Ministry of Health, Labour and Welfare. Medical fee revision. https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/0000106602.html. Accessed 1 Aug 2021. (in Japanese)."},{"key":"3657_CR2","first-page":"3","volume":"4","author":"M Murasaki","year":"2001","unstructured":"Murasaki M. Current status and prospects of psychotropic drugs in Japan \u2013aiming fror 21th century. Jpn J Clin Psychopharmacol. 2001;4:3\u201327 (in Japanese).","journal-title":"Jpn J Clin Psychopharmacol."},{"issue":"11","key":"3657_CR3","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1111\/jth.15033","volume":"18","author":"TY Chen","year":"2020","unstructured":"Chen TY, Winkelman JW, Mao WC, Tzeng NS, Kuo TBJ, Yang CCH, et al. Real-world evidence on the use of benzodiazepine receptor agonists and the risk of venous thromboembolism. J Thromb Haemost. 2020 Nov;18(11):2878\u201388.","journal-title":"J Thromb Haemost"},{"issue":"1","key":"3657_CR4","first-page":"43","volume":"129","author":"JY Lee","year":"2019","unstructured":"Lee JY, Farrell B, Holbrook AM. Deprescribing benzodiazepine receptor agonists taken for insomnia: a review and key messages from practice guidelines. Pol Arch Intern Med. 2019 Jan 31;129(1):43\u20139.","journal-title":"Pol Arch Intern Med"},{"issue":"11","key":"3657_CR5","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1007\/s40261-019-00838-w","volume":"39","author":"Y Hirano","year":"2019","unstructured":"Hirano Y, Ii Y. Changes in prescription of psychotropic drugs after introduction of Polypharmacy reduction policy in Japan based on a large-scale claims database. Clin Drug Investig. 2019 Nov;39(11):1077\u201392.","journal-title":"Clin Drug Investig"},{"key":"3657_CR6","doi-asserted-by":"crossref","unstructured":"Inada K, Enomoto M, Yamato K, Mishima K. Prescribing pattern of hypnotic medications in patients initiating treatment at Japanese hospitals: a Nationwide, Retrospective, Longitudinal, Observational Study Using a Claims Database. Drugs Real World Outcomes. 2021.","DOI":"10.1007\/s40801-021-00244-9"},{"issue":"2","key":"3657_CR7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2188\/jea.10.79","volume":"10","author":"Y Doi","year":"2000","unstructured":"Doi Y, Minowa M, Okawa M, Uchiyama M. Prevalence of sleep disturbance and hypnotic medication use in relation to sociodemographic factors in the general Japanese adult population. J Epidemiol. 2000;10(2):79\u201386.","journal-title":"J Epidemiol"},{"issue":"1","key":"3657_CR8","first-page":"14","volume":"7","author":"J Matsumoto","year":"2018","unstructured":"Matsumoto J, Hirano Y, Sudo C, Shimizu E, Yokote K. Relationship between the number of adult obesity and neuropsychiatric prescription drugs. Chiba Survey Res J. 2018;7(1):14\u201320.","journal-title":"Chiba Survey Res J"},{"key":"3657_CR9","doi-asserted-by":"crossref","unstructured":"Nakayama T, Imanaka Y, Okuno Y, Kato G, Kuroda T, Goto R, Tanaka S, Tamura H, Fukuhara S, Fukuma S, Muto M, Yanagita M, Yamamoto Y; BiDAME: Big Data Analysis of Medical Care for the Elderly in Kyoto. Analysis of the evidence-practice gap to facilitate proper medical care for the elderly: investigation, using databases, of utilization measures for National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB). Environ Health Prev Med. 2017;22(1):51.","DOI":"10.1186\/s12199-017-0644-5"},{"issue":"6","key":"3657_CR10","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s10157-019-01720-x","volume":"23","author":"R Inoue","year":"2019","unstructured":"Inoue R, Nishi H, Tanaka T, Nangaku M. Regional variance in patterns of prescriptions for chronic kidney disease in Japan. Clin Exp Nephrol. 2019;23(6):859\u201364.","journal-title":"Clin Exp Nephrol"},{"key":"3657_CR11","unstructured":"Ministry of Health, Labour and Welfare of Japan. NDB Open. https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/0000177182.html. Accessed 1 August 2021. (in Japanese)."},{"key":"3657_CR12","unstructured":"Chart of medical fees (April 2018). 1st ed. Tokyo: Igakutusinsya; 2018."},{"key":"3657_CR13","first-page":"1403","volume":"15","author":"A Inagaki","year":"2012","unstructured":"Inagaki A, Inada T. Dose equivalence of psychotropic drugs. Part 24: dose equivalence of anti-anxiolytics\/hypnotics: eszopiclone. Jpn J Clin Psychopharmacol. 2012;15:1403\u20136 (in Japanese).","journal-title":"Jpn J Clin Psychopharmacol"},{"key":"3657_CR14","unstructured":"Ministry of Internal Affairs and Communications. The Survey of population, demographics, and household number based on the basic resident register. https:\/\/www.e-stat.go.jp\/stat-search\/files?page=1&toukei=00200241&tstat=000001039591. Accessed 1 August 2021. (in Japanese)."},{"key":"3657_CR15","doi-asserted-by":"crossref","unstructured":"Taira K, Mori T, Ishimaru M, Iwagami M, Sakata N, Watanabe T, et al. Regional inequality in dental care utilization in Japan: an ecological study using the National Database of health insurance claims. Lancet Regional Health - Western Pacific. 2021.","DOI":"10.2139\/ssrn.3781694"},{"issue":"5","key":"3657_CR16","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s00198-019-04844-8","volume":"30","author":"J Tamaki","year":"2019","unstructured":"Tamaki J, Fujimori K, Ikehara S, Kamiya K, Nakatoh S, Okimoto N, et al. Iki M; working Group of Japan Osteoporosis Foundation. Estimates of hip fracture incidence in Japan using the National Health Insurance Claim Database in 2012-2015. Osteoporos Int. 2019 May;30(5):975\u201383.","journal-title":"Osteoporos Int"},{"key":"3657_CR17","unstructured":"Ministry of Internal Affairs and Communications. State of prefectures and municipalities (System of social and demographic statistics). https:\/\/www.e-stat.go.jp\/regional-statistics\/ssdsview. Accessed 1 August 2021. (in Japanese)."},{"key":"3657_CR18","doi-asserted-by":"crossref","unstructured":"Tsushita K, S Hosler A, Miura K, Ito Y, Fukuda T, Kitamura a, Tatara K. rationale and descriptive analysis of specific health guidance: the Nationwide lifestyle intervention program targeting metabolic syndrome in Japan. J Atheroscler Thromb 2018;25(4):308\u2013322.","DOI":"10.5551\/jat.42010"},{"key":"3657_CR19","unstructured":"R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. [cited 2021 October 14]. Available from: https:\/\/www.R-project.org\/."},{"key":"3657_CR20","volume-title":"Guidelines for medical treatment and its safety in the elderly 2015","author":"The Japan Geriatrics Society","year":"2015","unstructured":"The Japan Geriatrics Society. Guidelines for medical treatment and its safety in the elderly 2015. Tokyo: Medical View Co., Ltd.; 2015. (in Japanese)"},{"issue":"7","key":"3657_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0179472","volume":"12","author":"MT Wang","year":"2017","unstructured":"Wang MT, Wang YH, Chang HA, Tsai CL, Yang YS, Lin CW, et al. Benzodiazepine and Z-drug use and risk of pneumonia in patients with chronic kidney disease: a population-based nested case-control study. PLoS One. 2017;12(7):e0179472.","journal-title":"PLoS One"},{"key":"3657_CR22","first-page":"w14590","volume":"148","author":"T Grimmsmann","year":"2018","unstructured":"Grimmsmann T, Harden M, Fi\u00df T, Himmel W. The influence of hospitalisation on the initiation, continuation and discontinuation of benzodiazepines and Z-drugs - an observational study. Swiss Med Wkly. 2018 Feb 14;148:w14590.","journal-title":"Swiss Med Wkly"},{"key":"3657_CR23","doi-asserted-by":"crossref","unstructured":"American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60(4):616\u201331.","DOI":"10.1111\/j.1532-5415.2012.03923.x"},{"key":"3657_CR24","unstructured":"The Japanese Society of Sleep Research. Clinical Practice Guideline for the proper use and cessation of hypnotics. http:\/\/www.jssr.jp\/data\/pdf\/suiminyaku-guideline.pdf. Accessed 1 Aug 2021. (in Japanese)."},{"issue":"3","key":"3657_CR25","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1177\/0004867416664142","volume":"51","author":"Y Kachi","year":"2017","unstructured":"Kachi Y, Abe A, Ando E, Kawada T. Socioeconomic disparities in psychological distress in a nationally representative sample of Japanese adolescents: a time trend study. Aust N Z J Psychiatry. 2017;51(3):278\u201386.","journal-title":"Aust N Z J Psychiatry"},{"issue":"1","key":"3657_CR26","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s12199-011-0212-3","volume":"17","author":"Y Fukuda","year":"2012","unstructured":"Fukuda Y, Hiyoshi A. Influences of income and employment on psychological distress and depression treatment in Japanese adults. Environ Health Prev Med. 2012;17(1):10\u20137.","journal-title":"Environ Health Prev Med"},{"issue":"6","key":"3657_CR27","doi-asserted-by":"publisher","first-page":"701","DOI":"10.2486\/indhealth.2018-0031","volume":"57","author":"M Maeda","year":"2019","unstructured":"Maeda M, Filomeno R, Kawata Y, Sato T, Maruyama K, Wada H, et al. Association between unemployment and insomnia-related symptoms based on the comprehensive survey of living conditions: a large cross-sectional Japanese population survey. Ind Health. 2019;57(6):701\u201310.","journal-title":"Ind Health"},{"issue":"1","key":"3657_CR28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1093\/pubmed\/fdi067","volume":"28","author":"M Sekine","year":"2006","unstructured":"Sekine M, Chandola T, Martikainen P, McGeoghegan D, Marmot M, Kagamimori S. Explaining social inequalities in health by sleep: the Japanese civil servants study. J Public Health (Oxf). 2006;28(1):63\u201370.","journal-title":"J Public Health (Oxf)"},{"issue":"3","key":"3657_CR29","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.sleh.2020.02.016","volume":"6","author":"Y Ishibashi","year":"2020","unstructured":"Ishibashi Y, Shimura A. Association between work productivity and sleep health: a cross-sectional study in Japan. Sleep Health. 2020;6(3):270\u20136.","journal-title":"Sleep Health"},{"issue":"4","key":"3657_CR30","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s11136-009-9462-6","volume":"18","author":"SC Bolge","year":"2009","unstructured":"Bolge SC, Doan JF, Kannan H, Baran RW. Association of insomnia with quality of life, work productivity, and activity impairment. Qual Life Res. 2009;18(4):415\u201322.","journal-title":"Qual Life Res"},{"key":"3657_CR31","unstructured":"Ministry of Health, Labour and Welfare of Japan. Number of suicides among recipients of public assistance. ttps:\/\/www.mhlw.go.jp\/stf\/houdou\/2r98520000005olm-img\/2r98520000005oov.pdf. Accessed 1 Aug 2021. (in Japanese)."},{"issue":"4","key":"3657_CR32","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/MCO.0b013e3283479109","volume":"14","author":"G Beccuti","year":"2011","unstructured":"Beccuti G, Pannain S. Sleep and obesity. Curr Opin Clin Nutr Metab Care. 2011;14(4):402\u201312.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"3657_CR33","doi-asserted-by":"crossref","unstructured":"Izumida T, Nakamura Y, Sato Y, Ishikawa S. The association between sleeping pill use and metabolic syndrome in an apparently healthy population in Japan: JMS-II cohort study. J Epidemiol. 2020;7.","DOI":"10.2188\/jea.JE20200361"},{"issue":"8","key":"3657_CR34","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.comppsych.2012.03.011","volume":"53","author":"AC Maia","year":"2012","unstructured":"Maia AC, Braga Ade A, Brouwers A, Nardi AE. Oliveira e Silva AC. Prevalence of psychiatric disorders in patients with diabetes types 1 and 2. Compr Psychiatry. 2012;53(8):1169\u201373.","journal-title":"Compr Psychiatry"},{"issue":"11","key":"3657_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0166429","volume":"11","author":"T Sugai","year":"2016","unstructured":"Sugai T, Suzuki Y, Yamazaki M, Shimoda K, Mori T, Ozeki Y, et al. High prevalence of obesity, hypertension, hyperlipidemia, and diabetes mellitus in Japanese outpatients with schizophrenia: a Nationwide survey. PLoS One. 2016;11(11):e0166429.","journal-title":"PLoS One"},{"issue":"7","key":"3657_CR36","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1001\/jama.2014.8040","volume":"312","author":"L Ducat","year":"2014","unstructured":"Ducat L, Philipson LH, Anderson BJ. The mental health comorbidities of diabetes. JAMA. 2014;312(7):691\u20132.","journal-title":"JAMA."},{"key":"3657_CR37","doi-asserted-by":"crossref","unstructured":"Nakamura T, Nakamura Y, Saitoh S, Okamura T, Yanagita M, Yoshita K, Kita Y, Murakami Y, Yokomichi H, Nishi N, Okuda N, Kadota A, Ohkubo T, Ueshima H, Okayama A, Miura K. Relationship Between Socioeconomic Status and the Prevalence of Underweight, Overweight or Obesity in a General Japanese Population: NIPPON DATA 2010. J Epidemiol. 2018;28 (Suppl 3):S10-S16.","DOI":"10.2188\/jea.JE20170249"},{"issue":"4","key":"3657_CR38","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1080\/19338244.2010.486423","volume":"65","author":"Y Hayashino","year":"2010","unstructured":"Hayashino Y, Yamazaki S, Nakayama T, Sokejima S, Fukuhara S. The association between socioeconomic status and prevalence of diabetes mellitus in rural Japan. Arch Environ Occup Health. 2010;65(4):224\u20139.","journal-title":"Arch Environ Occup Health"},{"key":"3657_CR39","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1186\/1471-244X-13-338","volume":"13","author":"M Sado","year":"2013","unstructured":"Sado M, Takechi S, Inagaki A, Fujisawa D, Koreki A, Mimura M, et al. Cost of anxiety disorders in Japan in 2008: a prevalence-based approach. BMC Psychiatry. 2013;13:338.","journal-title":"BMC Psychiatry"},{"key":"3657_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/NDT.S15123","volume":"7","author":"AG Wade","year":"2010","unstructured":"Wade AG. The societal costs of insomnia. Neuropsychiatr Dis Treat. 2010;7:1\u201318.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"8","key":"3657_CR41","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/pcn.12894","volume":"73","author":"D Nishi","year":"2019","unstructured":"Nishi D, Ishikawa H, Kawakami N. Prevalence of mental disorders and mental health service use in Japan. Psychiatry Clin Neurosci. 2019;73(8):458\u201365.","journal-title":"Psychiatry Clin Neurosci"},{"key":"3657_CR42","unstructured":"Ministry of Health, Labour and Welfare of Japan. Patient Survey. https:\/\/www.e-stat.go.jp\/stat-search\/files?page=1&toukei=00450022&tstat=000001031167. Accessed 14 Oct 2021. (in Japanese)."},{"issue":"2","key":"3657_CR43","doi-asserted-by":"publisher","first-page":"836","DOI":"10.3390\/ijerph18020836","volume":"18","author":"Y Nagakura","year":"2021","unstructured":"Nagakura Y, Kato H, Asano S, Jinno Y, Tanei S. The significant association between health examination results and population health: a cross-sectional ecological study using a nation-wide health checkup database in Japan. Int J Environ Res Public Health. 2021;18(2):836.","journal-title":"Int J Environ Res Public Health"},{"key":"3657_CR44","unstructured":"Inoue H, Suzuki T, Kojima M, Inoshita E, Lee J, Tanaka S, Fujiyoshi A, Hayakawa T, Miura K. [factors related to life expectancy in prefectures: an ecological study using the National Database]. Nihon Koshu Eisei Zasshi. 2019;66(7):370-377. Japanese."}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-021-03657-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-021-03657-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-021-03657-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T00:13:11Z","timestamp":1700093591000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-021-03657-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,19]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3657"],"URL":"https:\/\/doi.org\/10.1186\/s12888-021-03657-6","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,19]]},"assertion":[{"value":"5 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the methods were carried out in accordance with relevant guidelines and regulations. An ethical approval by an institutional review board is not required for this study because we analyzed aggregated data that are publicly available as government statistics. Informed consent is also not needed for this study because we did not obtain the data from individual patients, and individual information are not included in the data.Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication."}},{"value":"The authors have no conflict of interest associated with the material presented in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44"}}